Saturday, January 25, 2020
Chronic Opiod Use after Hysterectomy
Chronic Opiod Use after Hysterectomy Specific Aims The rapid increase in the incidence of opioid-related overdoses and deaths has become a big public health threat in the United States. This opioid epidemic affects more women than men due to higher opioid prescribing and dose, longer period use, and more opioid dependence in women.1 From 1999 to 2010, the rate of opioid overdose caused death increased 5-fold among women.2 Besides the illicit purchase for some women, the initial exposure to opioids for many others may likewise come from the regular medical treatment as prescription opioids are widely used for pain management after surgery.3 As such, the critical research gap on opioids use is that the evidence is insufficient to draw conclusions about optimal strategies for initiation and titration of opioid therapy.4 Several observational studies have investigated the patterns of opioid use for noncancer pain in patients pre and post-surgery, and identified the risk factors of chronic opioid use post-surgery.5-11 Most of these studie s examined the prediction of baseline demographic and clinical characteristics of patients for prolonged opioid postoperative use and suggested that surgery is a risk factor for chronic opioid postoperative use.5-9 Only two studies examined the initial opioid exposure within 6 or 7 days of the surgery date and results are controversial.10,11 One study reported that initial exposure of opioid poses 44% increase risk of chronic postoperative opioid use and another one suggested that this risk would be low and statistically insignificant.10,11 Similar investigation has not been done specifically for hysterectomy, the most frequently performed non-obstetric surgeries in the United States for women of reproductive age.3,12 Pain has been demonstrated as a common symptom before and after hysterectomy.13,14 A small cross-sectional study has examined the predictors for opioid prescription in women of productive age and identified that opioid use was significantly associated with hysterectomy status and pain-related dysfunction.15 Another cross-sectional survey study reported that 32% patients had chronic pain after hysterectomy.14 Neither chronic opioid postoperative use nor initial opioid exposure for acute surgery pain was examined in these two studies.14,15 Filling this gap in knowledge is critical since identifying the risk factors of chronic opioid postoperative use could lead to optimized initial opioid prescribing for acute pain management and reduced chronic opioid postoperative use and improved women health. Our long-term goal is to help reduce chronic use of opioids and optimize the pain management in women after obstetric and gynecologic surgery through identification and dissemination the safer initial opioid prescribing for acute post-operative pain. Our objective here, which is the next step in our long-term goal, is to compare the patters of opioid use pre and post hysterectomy and determine the important risk factors that associate with chronic use of opioids in women post hysterectomy. The national OptumInsight Clinformatics data offers an essential resource to investigate these aims. The availability of clinical diagnoses and pharmacy medical dispensing offers a significant advantage for investigating drug utilization with corresponding clinical conditions in large population. Our team is well suited to conduct this research given extensive expertise in contemporary pharmacoepidemiology, many years of experience on opioid abuse research, prior drug utilization studies using large claims data, and clinical expertise from obstetric and gynecologic physicians. Our specific aims are to investigate patterns and predictors of chronic opioid use in women pre and post hysterectomy with the following analyses: Aim 1: To characterize the patterns of chronic opioid use in women after hysterectomy. Aim 2: To determine the significant risk factors for chronic use of opioids in women after hysterectomy. The first specific aim for this study is to identify patients who chronically take opioids during six months post hysterectomy, and investigate the time and geographical patterns of chronic opioid use in women after hysterectomy. The pattern of chronic opioid use pre- and post-surgery will also be compared in women with varied age, comorbidities, co-medications, as well as types and doses of initial opioid prescribing. The second specific aim is to determine the risk factors that significantly relate to chronic opioid use, and determine if characteristics of initial filled opioid prescriptions significantly associate with the chronic use of opioids after adjusting for other potential risk factors. Many pain related studies have demonstrated that long term opioid prescribing was significantly predicted by patients clinical characteristics and psychosocial factors, including pain conditions, psychiatric disorders, frequency of medical visits, smoking, and pain-related dysfunction.16-18 Therefore, the adjusted covariates in this study would include both demographic and clinical characteristics. B. Significance and Innovation Currently the United States is experiencing an unprecedented opioid epidemic. According to the Centers for Disease Control and Prevention (CDC), opioid-related deaths increased 200% overall from 2000 to 2014.19 During 2014, about 1.9 million people had an addiction of opioids, with overall 47,055 overdose deaths, 18,243 overdose deaths in women, and 18,893 overdose deaths related to prescription pain relievers.20,21 Based on the data reported by the CDC, women are more likely to have chronic pain, be prescribed opioids with higher dose and longer period, and hence progress to dependence.22 Although opioid abuse is a public health crisis, opioid analgesics are still the mainstay for treatment for acute pain after major surgery. In 2014, total 245 million prescriptions for opioids were dispensed from U.S. retail pharmacies.23,24 During 1998-2010, approximately 7.4 million hysterectomies were performed, making hysterectomy one of the most frequently performed surgeries for women in the United States.25 With over 60% of hysterectomies performed abdominally and up to 85% of patients experiencing moderate-to-severe pain after hysterectomy, postoperative pain management becomes very important.26,27 Evidence suggests that intense and long-lasting postsurgical pain can increase postsurgical morbidity, delay recovery, and lead to chronic pain.28 Opioids such as morphine, meperidine, and oxycodone are widely used postoperatively to reduce and manage pain in patients after hysterectomy.29 Women with hysterectomy and high levels of pain-related dysfunction were almost twice as likely to have opioid prescription. More than 85% of women with hysterectomy and a high level of pain-related dysfunction were found to use opioid.15 Hormonal disturbance, hyperalgesia, and iatrogenic effects are potential adverse effects from op ioid use in women after hysterectomy.14,15 The interaction of opioid-induced adverse effects and post-hysterectomy hormonal dysregulation may intensify pain and promote continued use of opioids.15 There are no known studies that evaluate the connection between acute and chronic postsurgical opiate prescription in women experienced hysterectomy. In consideration of the current opioid epidemic it is important to understand how post-surgical pain is managed, and if this setting presents increased risk of opioid addiction among certain groups, or related to particular prescribing practices. The goal of this proposed study is to examine whether opioids prescribed in women following hysterectomy is associated with chronic use of opioids, and to evaluate which factors may predict patterns of opioid use that indicate overuse or addiction. Accordingly, this study first aims to describe the incidence pattern of chronic opioid use in women post hysterectomy. The second aim is to explore the significant risk factors and determine if the characteristics of initial opioid prescribing significantly associate with chronic opioid use after adjusting for other potential risk factors. This study will reveal important insights regarding post-surgical pain management for a common procedure, and determine if certain patient or treatment characteristics increase the risk of chronic opioid use in this setting. We expect that this research will provide evidence for the need to improve clinical practice towards optimized pain management and reduced chronic opioid use in women after hysterectomy through identification the specific opioid, drug type (short-acting or long-acting), and doses that significantly associate with chronic opioid use in women after hysterectomy. Our study will provide sufficient evidence to draw conclusion about optimal strategies for initiation and titration of post-surgery opioid therapy, and enhance evidence-based medicine for opioid use in Rhode Island, and also the United State. This award would enhance my capabilities on handling interdisciplinary studies and further help me to develop my own research projects and seek for external funding. Innovation Our proposed observational studies based on the administrative claims data will allow for investigation of time trends and geographic variation of drug use in large population and address for well-characterized clinical conditions. Our approach will employ state of the art, innovative pharmacoepidemiologic study designs and statistical models, to improve the precision of outcome definition and minimize measured and unmeasured confounding and bias in our estimation of significant predictors for chronic opioid use after hysterectomy. The unintended outcomes from adverse drug effects make the prospective trials unethical. In this circumstance, a well-designed, retrospective observational study with sufficient sample size offers an efficient design to determine if there is an adequate signal for impropriate opioid prescribing to women post obstetrics and Gynecology surgery. The generalizability of study results are guaranteed due to the nationwide large health plan data that the analyses are based upon. C. Approach Data Sources Study data will be derived from the national OptumInsight Clinformatics Data MartTM, a research database spanning January 01, 2010 through December 31, 2013. The Optum Research Database includes about 23 million beneficiaries from the nationwide commercial health insurer, United Healthcare. The data contains health care utilization with transactional reimbursement data from outpatient pharmacy dispensing, inpatient and outpatient services.30 It links administrative enrollment data with the important medical codes including the national drug code (NDC) for pharmacy dispensing, the Current Procedural Terminology (CPT) code for medical procedure, and International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code for diagnosis. The claims data in this database have been adjudicated, ascertained, and deidentified for research purpose. The University of Rhode Island (URI) and OptumInsight Inc have approved utilization of these data. URI already licenses thi s database that it is freely available for faculties to use. Study Population This study will include adult women who receive the hysterectomy surgery between July 01 2010 and June 31 2013 and have at least 6 months of continuous prior coverage under this health insurance plan. This continuous 6-month coverage provides a baseline for defining new drug users, as well as baseline clinical characteristics, such as comorbidities and co-medications. The hysterectomy procedures will be derived from the ICD-9-CM diagnostic codes 68.3x-68.7x, and 68.9x, where 68.3x indicates a subtotal abdominal hysterectomy, 68.4x indicates a total abdominal hysterectomy, 68.5x indicates a vaginal hysterectomy, 68.6x indicates a radical abdominal hysterectomy, 68.7x indicates a radical vaginal hysterectomy, and 68.9x indicates other and unspecified hysterectomy.13,31 Patients with pelvic evisceration (ICD-9-CM: 68.8x) will be excluded. We also will exclude patients with any cancer diagnoses, including malignant neoplasm of the female genitourinary organs-cancer (ICD-9-CM: 179-184), a nd carcinoma in situ of female genitourinary system (ICD-9-CM: 233). Exposure Assessment Opioids in this study include the following medications: codeine, fentanyl, hydrocodone, hydromorphone, meperidine, methadone, morphine, oxycodone, and oxymorphone. Tramadol and propoxyphene, considered as weak opioids or already off market, will not be included.11,15 The exposure group involves adult women who receive the hysterectomy surgery and fill more than one prescription for opioids on the day of hospital discharge or within 7 days after hysterectomy surgery, provided that they have no exposure to opioids for at least 6 months prior to hysterectomy.11 The 7 days of window is based on the assumption that a filled prescription during this period would likely to treat acute postoperative pain caused by hysterectomy. A comparison group, defined as the patients with no opioids use on the day of hospital discharge or within 7 days after hysterectomy surgery, will serve as a control to make a comparison of risks for chronic use of opioids. The control patients also have no exposure to opioids for at least 6 months prior to hysterectomy. The exposure of opioids will be identified using NDC codes from pharmacy claims data. In this study, exposure assessment includes all characteristics of the initial filled opioid prescription at the day of hospital discharge from hysterectomy or during 7 days post-hysterectomy. The different type of opioids (classified as long or short acting), number of supply days, and oral morphine equivalent daily dose (milligrams) will be assessed and analyzed. Outcome Assessment Since the study focuses on the risk of chronic opioid use after initial exposure to opioids following hysterectomy, patients were followed from the 8th day after hysterectomy to the first day of outcome occurrence. The outcome, chronic use of opioids after hysterectomy, will be defined using trajectory models.11 in which patients with similar patterns of medication filling during follow-up will be grouped together. The trajectory model was initially generated for the purpose of the assessment of medication adherence.32,33 In order to classify the trajectory groups for opioid use during the defined follow-up window, we first generate 6 dichotomous variables to indicate if a study participant fills a prescription of an opioid medication during each of 6 consecutive 30 day follow-up periods.11 we then model these 6 binary indicators of using opioids in each 30 day follow-up period as a longitudinal response in a logistic group-based trajectory.34,35 With a trajectory model, we will estimate the probability of membership of patients in each group, and the probability of the certain opioid exposure over time as a smooth function of time. We will fit the model using 2 to 4 opioid exposure groups with comparison of the Bayesian Information Criterion.36 The number of groups will be chosen based on the value of the Bayesian Information Criterion. In each group, a third-order polynomial (including linear, squared, and cubic terms) of time will be used to model the probability of being exposed to opioids. Patien ts will be assigned to different trajectory groups, which are generated from these models and have highest probability of the membership. Based on the model results, the group of patients with the highest probability of filling opioids over time will be defined as the chronic use. Other trajectory groups were classified as nonchronic users. The trajectory models provide new advanced approaches to utilize the observed data to determine distinct filling patterns of opioids in our study population during the year after hysterectomy surgery. It classifies patients into groups with similar opioid exposure patterns without relying on a priori and subjective cutoff line for the definition of chronic opioid use. The trajectory models will be conducted using SAS Proc Traj (SAS, version 9.4, SAS Institute Inc., Cary, NC, USA). Patterns of Chronic Opioid Use After chronic opioid use is defined using trajectory models, we will compare the frequency of the incidence of chronic opioid use over time from 2010 to 2013. The secular trend will be analyzed using Joinpoint regression program (National Cancer Institute, Calverton, MD) to identify the joint points and slopes. The rates of chronic opioid use in women post hysterectomy will also be compared with varied age, comorbidities, co-medications, as well as characteristics of initial opioids exposure, including opioid types and doses. The geographic variation of chronic opioid use will be mapped and analyzed using ArcGIS 10.5 geographic information systems software (ESRI, Redlands, CA). The opioid prescription policies and socioeconomic status in different states will be compared with the geographic variation of chronic opioid use. Predictors of Chronic Opioid Use We will identify the predictors of chronic opioid use at baseline or the time of the initial opioid prescription. A previous study demonstrated that hysterectomy, older age, and higher levels of pain-related dysfunction were associated with opioid prescription.15 Potential predictors in this study would include age, year of surgery, smoking, illicit substance abuse, alcohol abuse, hysterectomy type, psychotropic medication use, pre-operative depression, pre-operative pain condition, primary indication for hysterectomy, co-medications, and characteristics of the initial opioid exposure. Although the benefits of minimally invasive surgical procedures have been documented,37 hysterectomies performed for benign indications in 2010 in the US still consisted of 40.1% total or subtotal abdominal hysterectomies, 30.5% laparoscopic hysterectomy, 19.9% vaginal hysterectomy, and 9.5% robotic-assisted hysterectomy.21,25 Hysterectomy type has been related to the initial opioid prescription,15 how ever, the results from randomized clinical trials showed that abdominal hysterectomies didnt increase postoperative chronic pain.38,39 The primary indication for hysterectomy is defined based on the following algorithm: (i) precancerous conditions will be assigned the primary indication if endometrial cystic hyperplasia or carcinoma in situ of female genitourinary system is listed as an indication associated with hysterectomy surgery; (ii) whichever is listed first of endometriosis, uterine prolapse, or uterine leiomyoma will be assigned the primary diagnosis associated with hysterectomy if cancer or a precancerous condition is not listed; (iii) endometrial cystic hyperplasia is combined with in situ under precancerous and that pain and bleeding were included as reported reasons for hysterectomy, and (iv) other was assigned the leading for the remaining diagnoses.19 Over 60% of patients have reported pain as pre-operative symptoms for hysterectomy.39 After hysterectomy, the prevalent pain was reduced to 4.7% to 31.9% during 1-2 years after surgery, while new onset pain at follow-up was reported in 1-14.9% patients and increased pain was in 2.9-5% of patients with pre-operative pelvic pain.39 Therefore, in our study, we plan to assess pre- and post-operative pain, as well as the pain conditions, including pelvic pain, back pain, fibromyalgia, and migraine or other headache syndromes using ICD-9-CM codes. Patients with pharmacy claims for opioids or diagnoses for opioid abuse (ICD-9-CM: 304.xx) during the 6-month baseline period will be identified as opioid users prior to hysterectomy. Preoperative depression that has been found significantly associated with postoperative chronic pain,40 will be identified using diagnoses, as well as medication use at baseline. Antipsychotropic medication use will be obtained using prescription information. The psychiatric comorbidity, will be assessed using prescription information instead of ICD-9-CM codes for greater specificity.11 Co-medications refer to the use of other medications on postoperative pain management. The postoperative use of Nonsteroidal anti-inflammatory drugs (NSAIDs) or Acetaminophen with opioids has been found safe and effective on pain relieve with reduced opioid dose.41 All potential predictors, including characteristics of initial opioid use, will be adjusted in multivariate analyses to identify the significant predictors for chronic use of opioids in patients post hysterectomy. Statistical Analysis Statistical tests and modeling will be conducted to identify potential significant risk factors for chronic use of prescribed opioids in women post-hysterectomy. Categorical variables will be examined and compared using Chi square or the Fisher exact test. Continuous variables will be compared using the student t test. The covariates will be selected from all demographic and clinical variables using statistical modeling. A univariate analysis will be performed with the initial opioid exposure variable and then with each covariate added one at a time to monitor the change of the estimate of the major exposure variable. The covariates that modify the estimate of opioid exposure (variable >5%) or significantly predict the chronic use of opioids will be selected for further multivariate analysis. To account for many confounding factors, we will also utilize propensity score matching method to combine all confounding factors into a propensity score. The patients with initial opioid exposu re will be 1:5 matched with the patients without initial opioid exposure using the propensity score with a caliper of 0.01. A multivariate conditional logistic regression model will be utilized to measure the adjusted odds ratio of initial opioid exposure on chronic opioid use in two matched groups. A probability of type 1 error (alpha) = 0.05 will be considered to be the threshold of statistical significance. Tukey-Kramer method will be applied to correct the inflated p value due to multiple comparisons. Statistical analysis will be performed using SAS software (version 9.4, Cary, NC). Sensitivity Studies In order to address unmeasured confounding factors, sensitivity analyses will be conducted in two sections: subgroup analyses and instrumental variables. Subgroup analysis In order to investigate the effects of initial opioid exposure in women post hysterectomy, multivariate analysis will be conducted in the following subgroups: women with postoperative chronic pain, women without postoperative chronic pain, women with postoperative NSAIDs use, women without postoperative NSAIDs use, women with postoperative Acetaminophen use, and women without postoperative Acetaminophen use. Interactions between the drug exposure and the important factors will be examined in the multivariate analyses. Subgroup analyses will likewise be conducted if the interaction is statistically significant. Instrumental Variable We plan to use propensity score matching to address all measurable confounding factors and generate two balanced comparison groups. However, the unmeasurable confounding factors, like confounding by indication, may still impact the study validity. Instrumental variable is an advanced methodology that has been utilized in pharmocoepidemiological studies to control for the unmeasurable confounding factors, such as confounding by indication. In the sensitivity study, we will use the physicians preference as an instrumental variable and reexamine the initial opioid exposure on chronic use of opioids post hysterectomy. D. Timeline Table. Study Timeline of the Study. Time Period Study Progress Before 07/01/2017 Obtain IRB approval and Optum data use permission 07/01/2017 08/01/2017 Complete data cleaning, manipulating, and variable editing. 08/01/2017 10/01/2017 Complete analyses for demographic and clinical characteristics 10/01/2017 01/31/2018 Complete trajectory modeling to determine chronic opioid use. Analyze the time and geographic trends. 02/01/2018 02/28/2018 Submit an abstract to the annual meeting of International Society of Pharmacoepidemiology (ISPE) 03/01/2018 06/30/2018 Complete analyses for specific aim 1 07/01/2018 01/31/2019 Complete predictive modeling as described in specific aim 2 02/01/2019 02/28/2019 Submit an R21 to NIH, and an abstract to the annual meeting of ISPE 03/01/2019 06/30/2019 Compete analyses for specific aim 2, including all sensitivity studies. Submit a final paper to a high impact journal 09/01/2017 12/15/2017 Complete course PHP 2090 01/01/2018 05/15/2018 Complete course PHP 2470
Friday, January 17, 2020
Military Commander & the Law Essay
Both in the civilian and the military population, the issue of legal drinking age has been a contentious issue. The proposal to lower the minimum drinking age among members of the military in different states has attracted a lot of debate all over the United States. The basic argument has been individuals who are able to defend the country and participate in combat missions in Afghanistan and Iraq among other areas are responsible enough to be allowed to legally buy and consume alcoholic drinks irrespective of the age. However, any debate that deals with changes in the law is always a controversial issue. There are a large number of people in support of the lowering of the drinking age in the military to 18 years irrespective of the laws in the state in which the military base is located. On the other hand, it has been opposed by a large number of individuals and groups (Bray & Hourani, 2007). However, it is important to note that if an individual is mature enough to take part in military duties, he is mature enough to drinking and therefore the drinking age in the military should be lowered to 18 years. Surveys carried out in the United States have always indicated that majority of Americans support the abolishment of legal drinking age limits in the military. The Americans are generally for the argument that all individuals in active duties in the armed forces should not be limited by the law to consume beer. Being a democratic country, the policy makers have no option but act according to the will of the majority. In the past, all military officials in active duty were allowed to consume alcohol in their military bases irrespective of the laws limiting the drinking age in the state. This changed in the 1980s when the congress enacted laws that required the states and federal laws on legal drinking age be enforced in the military bases (Powers, 2009). Since then, there have been suggestions to abolish this law in different states. The basic argument has always been if the individual is man enough to be in a battlefield, he should be able to handle beer responsibly. Common sense indicates that an individual is recruited and allowed to work in the military because they are adults and therefore should not be limited by the law (Hoellwarth, 2007). An 18 years individual in the United States has attained the majority age and is considered to have the ability to make informed decisions such as participating in general elections. The person can also take a weapon to defend his country. Does it make sense really for such a person to be denied the right to consume alcohol? I donââ¬â¢t think so. The common believe that tolerance to alcohol increases with age is not necessarily true. There are cases where younger people have been found to be more tolerant. Moreover, tolerance to alcohol is an issue of responsibility and discipline rather than age. Many young people serving in the US military are more responsible that some senior members of the society (Jacobson, et al, 2008). In conclusion, it does not make sense the limit the military personnel from consuming alcohol based on their age. The fact that they are mature enough to take part in combat missions and defend their country suggests that they are mature enough to control their drinking. Moreover, majority of the Americans are in support of abolishing legal drinking age in the military. Reference Bray R. M & Hourani L. L. (2007). ââ¬Å"Substance use trends among active duty military personnel: findings from the United States Department of Defense Health Related Behavior Surveys,â⬠1980-2005. Addiction; 102(7):1092-101 Gittins, R. A. (1996). The Military Commander & the Law, ISBN 0788172603, DIANE Publishing Hoellwarth, J. (2007). Corps lowers drinking age to 18 in some cases, Retrieved on July 22, 2010 from: http://www. marinecorpstimes. com/news/2007/05/marine_alcohol_070511/ Jacobson I. G, Ryan MAK, Hooper TI, Smith TC, et al. (2008). ââ¬Å"Alcohol use and alcohol-related problems before and after military combat deployment. â⬠JAMA; 300:663ââ¬â675. Powers, R. (2009). U. S. Military: Military Drinking Age. Retrieved on July 22, 2010 from: http://usmilitary. about. com/library/polls/blmildrinkingage. htm
Thursday, January 9, 2020
Wednesday, January 1, 2020
A Comprehensive Treatment Plan Based Off Diagnosis Of The...
Upon discussions and consultations with general dentistry, periodontics, prosthodontics, and endodontic professors, we have drawn a comprehensive treatment plan based off diagnosis of the problems at hand. Periodontitis, loss of tooth structure due to bruxism, fistula, and periapical abscess were the findings. Based from the presentation of patient, it is apparent patient is at high risk of periodontal issues and of caries. Included in appendix, are the clinical photos, radiographs, periodontal charts, study casts, and treatment plans. Scaling and Root Planning (SRP), prophylaxis, root canal therapy (RCT), post and core, porcelain fused metal crown, and night guard were the major treatments. While broken teeth and possible cariesâ⬠¦show more contentâ⬠¦2), Autologous platelet concentrates (APC) for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature is a quality paper. Massimo et al. focused on finding out the differe nce between the group exposed to APC vs. the group Not exposed to APC, in regard to surgical dental treatments, in terms of a) improving success of surgical treatment of BRONJ, b) reducing the incidence of BRONJC after oral surgery procedures, furthermore, 1) improving healing of bone and soft tissue at the surgical site, 2) reducing incidence of any other post-surgical complication and side-effect, 3) improving patientââ¬â¢s quality of life by reducing pain, swelling, and other common symptoms, in the post-surgical period, increasing treatment acceptance by patient, in patient under bisphosphonate treatment world-wide. This paper analyzed original clinical studies including prospective and retrospective, on surgical treatment and prevention. The meta-analysis combined 2 case series and 1 case control but excludes case report and non-outcome study. The studies included address the review question, have appropriate study design, with clear search strategy, The article utilized Cochrane Central Register of Controlled Trials, MEDLINE, and Scopus bibliographic databases that were not limited to just English studies. Also, Del Fabbro et al.Show MoreRelatedAlcohol Use Disorder Identification Test1569 Words à |à 6 Pagespropelled by unique problems and conditions. Generally, many people will look for therapy because of sense of dissatisfaction with emotional pain or life. Sometimes it can be from immediate distress that is related to a definite crisis like addiction, separation or a loss, maybe on ongoing difficulty in part of their lives like work or relationship. For some people it might be due to suffering strong sadness, worry or fear. To some extent individuals might not have a clear external problem, but having innerRead MoreThe Issue Of Mental Illness Essay1666 Words à |à 7 Pagesmental illness as being a condition that affects a person s thinking, feeling or mood. Such conditions may affect someone s ability to relate to others and function each day. Each person will have different experiences, even people with the same diagnosis. The 4 presidential candidates that will be written about are: Hillary Clinton, Donald Trump, Jill Stein and Gary Johnson. As the 2016 elections are near, the 4 presidential candidates have informed voters, viewers and the media on their stancesRead MoreRelationship Between Mental Health And Addiction1470 Words à |à 6 Pagesyou or someone you love is seeking treatment for a substance abuse related disorder in addition to a psychiatric disorder, you will come across two terms in your research: co-occurring disorders and dual diagnosis. Right off you may be more concerned about simply getting help for your addiction. Maybe it has caused you to lose your job and your family is in tatters. It s important to note that when substance abuse and mental illness co-occur specialized treatment is needed. First, however, you mustRead MoreThe Components Of The Evaluation Process1540 Words à |à 7 PagesWhen beginning treatment for someone dealing with alcohol abuse or dependence, there is a specific process that must be undergone. The components of the evaluation process are as follows: (1) screening, (2) diagnosis, (3) assessment, (4) motivation, (5) treatment, and (6) follow-up. All of these are essential to proper treatment for clients dealing with alcohol problems. For the sake of this paper, focus will be directed purposefully towards the process of assessment. When any indication of alcoholRead MoreEvaluation Of The Nursing Process1417 Words à |à 6 PagesThe second step is diagnosis; this is the process of identifying problems. It is written as a two or three part statement. The nursing diagnosis derives from evidence previously collected in the nursing assessment. It is s a statement regarding the patients expected or actual health problem. When coming up with a nursing diagnosis it is important to compare data with averages or norms, cluster data, analyz e data, and decide which nursing diagnosis is priority based on what problem could possibly endangersRead MoreAttention Deficit Hyperactivity Disorder ( Adhd )1411 Words à |à 6 Pageshome, school, improper behavior in normal circumstances, and or a persistent mood of unhappiness (Salmon, 2006). In school, students with EBD tend to act out, stay off task, and disobey rules. In a typical day students spent in school, 70% of that time spent working on independent tasks. During this time, students with EBT have problems with interacting and keep attention on tasks, as a result of the rate of such behaviors, teachers usually become frustrated when dealing with difficult situation (SalmonRead MoreIntervention Methods. Methods Proposed To Achieve The Programââ¬â¢S1175 Words à |à 5 Pagesserve. Theories of Underlying Interventions A treatment method suited to meet the goals of the CSH are interventions based on the Family-Center Approach. In brief, ââ¬Å"definitions of family-centered services generally include such descriptors as strengths-based, family-driven, culturally responsive, empowerment-focused, and collaborative partnership (Madsen, 2009). Logic Within the Program Most treatment plans for CSH clients start with a comprehensive assessment, including pyscho-diagnostic evaluationsRead MoreAnalysis Of The Movie Black Swan 3393 Words à |à 14 Pagescriteria for a Schizophrenia spectrum disorder, followed by current research on schizophrenia and recommended treatment. Because specific temporal information is unavailable and the key difference between schizophreniform disorder and schizophrenia is duration, the diagnosis made for the purpose of this paper is schizophrenia. The research portion will cover current research and treatment of schizophrenia. Schizophrenia is a disorder defined by a heterogeneous set of irregularities across multipleRead MoreCompetitive Business Environment At T And Verizon1746 Words à |à 7 Pagesleaders such as Sprint, ATT and Verizon leverage their industry-leading wireless and wireline networks to develop employee benefit solutions focused on comprehensive employee benefit packages. Sprint, ATT and Verizon seek alliances that provide complementary capabilities and a strong brand within the marketplace, all the while expanding their benefits plan in order to entice and retain employees. Even in a long line of emerging telecom organizations. It can be said Sprint, ATT and Verizon have beenRead MoreOverview Of Professional Experience And Plans Essay1584 Words à |à 7 PagesOverview of Professional Experience and Plans I first became interested in psychology while enrolled in a grade eleven introductory course. Learning the basics about human behaviour and mental processes fascinated me, and from there I began to explore the ways in which psychology could become a lifelong career. Fast-forward seven years and I have witnessed this passion flourish through the completion of my Bachelor of Arts Honours degree in Psychology and my Developmental Services Worker Diploma
Subscribe to:
Posts (Atom)